Roivant Sciences Ltd. s (NASDAQ: ROIV) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ROIVANT SCIENCES LTD. S

Roivant Sciences Ltd. s (NASDAQ: ROIV)
Listen to this Section


$35.97
-0.0050 ( -0.01% ) 0.0K

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Market Data


Open $35.97
Previous Close $35.97
Volume 0.0K
Market Cap $25.87B
Day Range $35.78 - $35.98
52 Week Range $10.90 - $37.00
Shares Outstanding 719.27M
Change % -0.01%
Net Change ▼ -0.0050
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2021
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 3,315.00

Date Type Amount Purchased Purchaser
2025-09-18 Buy 3315.00 Gline Matthew

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jul 30, 2025
3 Insider transactions 2 Jul 29, 2025
ars Annual reports 1 Jul 29, 2025
def Proxies and info statements 26 Jul 29, 2025
4 Insider transactions 1 Jul 23, 2025
4 Insider transactions 1 Jul 21, 2025
4 Insider transactions 1 Jul 21, 2025
4 Insider transactions 1 Jul 21, 2025
4 Insider transactions 1 Jul 01, 2025

Latest News